The management team is a joke honestly. They have fumbled and bumbled there way through the last 2 years and want pay rises and performance shares.
It is laughable. The stock only goes one way and that is a direct result of their appalling management of what should be a blockbuster new drug and an exciting company to be invested in.
2022 PAR AGM, page-3
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
23.5¢ |
Change
0.005(2.17%) |
Mkt cap ! $83.95M | |||
| Open | High | Low | Value | Volume |
| 23.0¢ | 25.0¢ | 23.0¢ | $138.4K | 588.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 26062 | 23.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.0¢ | 19358 | 5 |
View Market Depth
| Last trade - 14.25pm 06/08/2024 (20 minute delay) ? |
| PAR (ASX) Chart |